Protective effects of renal ischemic preconditioning and adenosine pretreatment: Role of A1 and A3 receptors

American Journal of Physiology - Renal Physiology

Volumn 278, Issue 3 47-3, 2000, Pages

  Lee, H Thomas ^a,b   Emala, Charles W ^a  

^a Columbia University ^*  (United States)

^b Milstein Hospital   (United States)

Author keywords

Acute renal failure; Adenosine; Ischemic reperfusion injury; Kidney

Indexed keywords

ADENOSINE A1 RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG RECEPTOR BINDING; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY ISCHEMIA; MAJOR SURGERY; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

EID: 0034062959     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.2000.278.3.f380     Document Type: Article

References (53)

1. Aronson, S., and R. Blumenthal. Perioperative renal dysfunction and cardiovascular anesthesia: concerns and controversies. J. Cardiothorac. Vasc. Anesth. 17: 117-130, 1998.
2. Beach, R. E., B. A. Watts III, D. W. Good, C. R. Benedict, and T. D. DuBose. Effects of graded oxygen tension on adenosine release by renal medullary and thick ascending limb suspensions. Kidney Int. 39: 839-842, 1999.
3. Blanco, J., E. I. Canela, J. Mallol, C. Lluis, and R. Franco. Characterization of adenosine receptors in brush-border membranes from pig kidney. Br. J. Pharmacol. 107: 671-678, 1992.
4. Brezis, M. Cellular mechanisms of acute ischemic injury in the kidney. Annu. Rev. Med. 44: 27-37, 1993.
5. Churchill, P. C., and A. K. Bidani. Hypothesis: adenosine mediates hemodynamic changes in renal failure. Med. Hypotheses 8: 275-285, 1982.
6. Churchill, P. C., and A. K. Bidani. Renal effects of selective adenosine receptor agonists in anesthetized rats. Am. J. Physiol. Renal Fluid Electrolyte Physiol. 252: F299-F303, 1987.
7. Dinour, D., Y. Agmon, and M. Brezis. Adenosine: an emerging role in the control of renal medullary oxygenation? Exp. Nephrol. 1: 152-157, 1993.
8. Egan, J. C., T. J. Knolmayer, M. W. Bowyer, L. Sun, and H. T. Lee. Systemic pretreatment with adenosine preserves rabbit renal function after ischemia and reperfusion (Abstract). Anesthesiology 89: A390, 1998.
9. Engelman, D. T., C. Z. Chen, M. Watanabe, R. M. Engelman, J. A. Rousou, J. E. Flack, D. W. Deaton, N. Maulik, and D. K. Das. Improved 4- and 6-h myocardial preservation by hypoxic preconditioning. Circulation 92, Suppl. II: II-417-II-422, 1995.
10. Frank, R. S., T. S. Frank, G. B. Zelenock, and L. G. D'Alecy. Ischemia with intermittent reperfusion reduces functional and morphologic damage following renal ischemia in the rat. Ann. Vasc. Surg. 7: 150-155, 1993.
11. 2-induced acute renal failure in rats. Renal Physiol. 5: 245-255, 1982.
12. Goto, M., Y. Liu, X. M. Yang, J. L. Ardell, M. V. Cohen, and J. M. Downey. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ. Res. 77: 611-621, 1995.
13. + channels in cerebral ischemic preconditioning. Proc. Natl. Acad. Sci. USA 92: 4666-4670, 1995.
14. 1b-adrenoreceptors, pertussis toxin sensitive G proteins, and protein kinase C. Circulation 92: 2259-2265, 1995.
15. Huber, T. S., T. R. S. Harward, T. C. Flynn, J. L. Albright, and J. M. Seeger. Operative mortality rates after elective infrarenal aortic reconstructions. J. Vasc. Surg. 22: 287-294, 1995.
16. Ikonomidis, J. S., R. D. Weisel, and D. A. G. Mickle. Ischemic preconditioning: cardioprotection for cardiac surgery. J. Cardiovasc. Surg. 3, Suppl. 3: 526-531, 1994.
17. Islam, C. F., R. T. Mathie, M. D. Dinneen, E. A. Kiely, A. M. Peters, and P. A. Graces. Ischaemia-reperfusion injury in the rat kidney: the effect of preconditioning. Br. J. Urol. 79: 842-847, 1997.
18. Jablonski, P., B. O. Howden, D. A. Rae, C. S. Birrel, V. C. Marshall, and J. Tange. An experimental model for assessment of renal recovery from warm ischemia. Transplantation 35: 198-204, 1983.
19. Kehoe, B., G. R. Keeton, and C. Hill. Elevated plasma renin activity associated with renal dysfunction. Nephron 44: 51-57, 1986.
20. Kerrigan, C. L., and M. A. Stotland. Ischemic reperfusion injury: a review. Microsurgery 14: 165-175, 1993.
21. 3 receptor agonists. Biochem. Biophys. Res. Commun. 232: 904-910, 1996.
22. Lee, H. T., and W. C. Lineweaver. Protection against ischemic-reperfusion injury of skeletal muscle: role of ischemic preconditioning and adenosine pretreatment. J. Reconstruct. Microsurg. 12: 383-388, 1996.
23. Lee, H. T., C. A. Schroeder, P. Shah, S. Babu, C. I. Thompson, and F. L. Belloni. Preconditioning with ischemia or adenosine protects skeletal muscle from ischemic tissue reperfusion injury. J. Surg. Res. 63: 29-34, 1996.
24. Lin, J. J., P. C. Churchill, and A. K. Bidani. Effect of theophylline on the initiation phase of postischemic acute renal failure in rats. J. Lab. Clin. Med. 108: 150-154, 1986.
25. Lin, J. J., P. C. Churchill, and A. K. Bidani. Theophylline in rats during maintenance phase of postischemic acute renal failure. Kidney Int. 33: 24-28, 1988.
26. 1 adenosine receptors in rabbit heart. Circulation 84: 350-356, 1991.
27. Maher, E. R., K. N. Robinson, J. E. Scoble, J. G. Farrimond, D. R. Browne, P. Sweeny, and J. F. Morehead. Prognosis of critically-ill patients with acute renal failure: APACHE II score and other predictive factors. Q. J. Med. 72: 857-866, 1989.
28. McCarthy, J. T. Prognosis of patients with acute renal failure in the intensive care unit: a tail of two eras. Mayo Clinic. Proc. 71: 117-126, 1996.
29. McComs, P. R., and B. Roberts. Acute renal failure following resection of abdominal aortic aneurysm. Surg. Gynecol. Obstet. 148: 175-178, 1979.
30. Meldrum, D. R. Mechanisms of ischemic preconditioning: ten years after the discovery of ischemic preconditioning. J. Surg. Res. 73: 1-13, 1997.
31. Murry, C. E., R. B. Jennings, and K. A. Reimer. Preconditioning with ischemia. A delay of lethal cellular injury in ischemic myocardium. Circulation 74: 1124-1136, 1986.
32. Olah, M. E., and G. L. Stiles. Adenosine receptor subtypes: characterization and therapeutic regulation. Annu. Rev. Pharmacol. Toxicol. 35: 581-606, 1995.
33. Osswald, H., H. J. Schmitz, and R. Kemper. Tissue content of adenosine, inosine and hypoxanthine in the rat kidney after ischemia and post-ischemic recirculation. Pflügers Arch. 371: 45-49, 1977.
34. 2 receptors. Hepatology 29: 126-132, 1999.
35. Ralevic, V., and G. Burnstock. Receptors for purines and pyrimidines. Pharmacol. Rev. 50: 413-492, 1998.
36. Reimer, K. A., and R. B. Jennings. Ischemic preconditioning: a brief review. Basic Res. Cardiol. 91: 1-4, 1996.
37. 2-induced acute renal failure in rats. Am. J. Physiol. Renal Fluid Electrolyte Physiol. 258: F1554-F1560, 1990.
38. Schirmer, H. K. A. The effect of intermittent and prolonged renal artery occlusion upon respiratioin and anaerobic glycolysis of dog kidney. J. Urol. 94: 511-513, 1965.
39. Schultz, J. E., A. K. Hsu, and G. J. Gross. Morphine mimics the cardioprotective effect of ischemic preconditioning via glibenclamide-sensitive mechanism in the rat heart. Circ. Res. 78: 1100-1104, 1996.
40. 3 adenosine receptor agonist. Exp. Cell Res. 243: 383-397, 1998.
41. Spielman, W. S., and L. J. Arend. Adenosine receptors and signalling in the kidney. Hypertension 17: 117-130, 1991.
42. 1-selective adenosine analogues protects the heart against infarction. Circ. Res. 85: 659-665, 1992.
43. Truss, F. Advantages and disadvantages of intermittent pedicle clamping in renal preserving surgery. Br. J. Urol. 43: 35-38, 1971.
44. 1-Adrenergic agonists preconditionig rabbit ischemic myocardium independent of adenosine by direct activation of protein kinase C. Circ. Res. 85: 576-585, 1994.
45. Turman, M. A., and C. M. Bates. Susceptibility of human proximal tubular cells to hypoxia: effect of hypoxic preconditioning and comparison to glomerular cells. Renal Failure 19: 47-60, 1997.
46. 3 receptor stimulation on seizures in mice. Eur. J. Pharmacol. 275: 23-29, 1995.
47. 6-cyclopentyl adenosine and 8-cyclopentyl-1,3,-dipropylxanthine on N-methyl-D-aspartate induced seizures in mice. Eur. J. Pharmacol. 249: 265-270, 1993.
48. Wall, T. M., R. Sheehy, and J. C. Hartman. Role of bradykinin in myocardial preconditioning. J. Pharmacol. Exp. Ther. 270: 681-689, 1994.
49. Weaver, D. R., and S. M. Reppert. Adenosine receptor gene expression in the kidney. Am. J. Physiol. Renal Fluid Electrolyte Physiol. 263: F991-F995, 1992.
50. Yao, Z., and G. J. Gross. ACh mimics ischemic preconditioning via a glibenclamide-sensitive mechanism in dogs. Am. J. Physiol. Heart Circ. Physiol. 264: H2221-H2225, 1993.
51. Yellon, D. M., G. F. Baxter, D. Garcia-Dorado, G. Heusch, and M. S. Sumeray. Ischemic preconditioning: present and future directions. Cardiovasc. Res. 37: 21-33, 1998.
52. Zager, R. A., L. A. Baltes, H. M. Sharma, and M. S. Jurkowitz. Responses of the ischemic acute renal failure kidney to sequential ischemic events. Kidney Int. 26: 689-700, 1984.
53. Zager, R. A., M. S. Jurkowitz, and A. J. Merola. Responses of the normal rat kidney to sequential ischemic events. Am. J. Physiol. Renal Fluid Electrolyte Physiol. 249: F148-F159, 1985.